Psychological Intervention for Persons in the Early Initial Prodromal State
NCT ID: NCT00204087
Last Updated: 2006-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
126 participants
INTERVENTIONAL
2001-01-31
2005-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive behavioral therapy (CBT)
Supportive Counselling (SC)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 17 and 36 years
* male or female, in- or outpatients
* written informed consent, for patients below 18 years also signed by their parents
2. Special criteria (presented within the last three months prior to the study)
1. Self-experienced neuropsychological deficits (basic symptoms)
* Thought interferences
* Compulsory like perseverance of thoughts
* Thought pressure
* Thought blockages
* Disturbances of receptive language, either heard or read
* Decreased ability to discriminate between ideas and perception, fantasy and true memories
* Unstable ideas of reference (subject-centrism)
* Derealisation
* Visual perceptual disturbances (blurred vision, transitory blindness, partial seeing, hypersensitivity of light, etc..)
* Acoustic perceptual disturbances (hypersensitivity to sounds or noise (hypersensitivity to sounds or noise, acoasms, etc.) AND/OR
2. Reduction in the Global Assessment of Functioning Score (DSM IV) of at least 30 points (within the past year) and at least one of the following risk factors:
* First-degree relative with a lifetime-diagnosis of schizophrenia or
* a schizophrenia spectrum disorder
* Pre-or perinatal complications
Exclusion Criteria
* Present or past diagnosis of a schizophrenic, schizophreniform, schizoaffective, delusional or bipolar according to DSM IV
* Present or past diagnosis a brief psychotic disorder according to DSM IV with a duration of more than one week or within the last 4 weeks regardless of its duration
* Diagnosis of delirium, dementia, amnestic or other cognitive disorder, mental retardation psychiatric disorder due to a somatic factor or related to the consumption of psychotropic substances according DSM IV
* Alcohol- or drug abuse within the last three months prior to inclusion according to DSM IV
* Deases of the central nervous system (inflammatory, traumatic, epilepsy etc.)
17 Years
36 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
German Federal Ministry of Education and Research
OTHER_GOV
German Research Network On Schizophrenia
NETWORK
Department of Psychiatry University of Bonn
OTHER
Heinrich-Heine University, Duesseldorf
OTHER
Ludwig-Maximilians - University of Munich
OTHER
University of Cologne
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Bechdolf, Dr.
Role: STUDY_CHAIR
Department of Psychiatry and Psychotherapy, University of Cologne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Psychiatry and Psychotherapy, University of Cologne
Cologne, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wessels H, Wagner M, Kuhr K, Berning J, Putzfeld V, Janssen B, Bottlender R, Maurer K, Moller HJ, Gaebel W, Hafner H, Maier W, Klosterkotter J, Bechdolf A. Predictors of treatment response to psychological interventions in people at clinical high risk of first-episode psychosis. Early Interv Psychiatry. 2019 Feb;13(1):120-127. doi: 10.1111/eip.12460. Epub 2017 Jul 4.
Bechdolf A, Wagner M, Ruhrmann S, Harrigan S, Putzfeld V, Pukrop R, Brockhaus-Dumke A, Berning J, Janssen B, Decker P, Bottlender R, Maurer K, Moller HJ, Gaebel W, Hafner H, Maier W, Klosterkotter J. Preventing progression to first-episode psychosis in early initial prodromal states. Br J Psychiatry. 2012 Jan;200(1):22-9. doi: 10.1192/bjp.bp.109.066357. Epub 2011 Nov 10.
Related Links
Access external resources that provide additional context or updates about the study.
Click here for more information about this study: Psychological intervention for persons at risk of psychosis in the early initial prodromal state
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01 GI 9935 - P 1.1.2
Identifier Type: -
Identifier Source: org_study_id